Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Japan
  4. Japan Exchange
  5. HORIBA, Ltd.
  6. News
  7. Summary
    6856   JP3853000002

HORIBA, LTD.

(6856)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

HORIBA : to showcase novel POCKIT Central PCR analyzer at BEVA and Vets North ...

08/17/2021 | 05:13am EDT

Why wait for results? Vets can see for themselves how easy it is to do in-house PCR testing.

HORIBA UK Limited will be showcasing its new benchtop POCKIT™ Central* in-house veterinary PCR analyzer on Stand C3 at the BEVA Congress, Birmingham, 4-7 September. HORIBA's first live event this year will give visitors the opportunity to see how easy it is to carry out in-house PCR Testing on the POCKIT Central. The simple 'sample in, result out' process provides fast, accurate PCR testing in only in 85 mins for up to 8 pathogens in one run. Ideally suited to veterinary practices, the POCKIT Central ensures confident diagnostic and case management decision making without needing to wait for external laboratory results.

The POCKIT Central offers more than 190 PCR tests, including over 30 new ones, tailored to Equine, Small Animal and Farm practices, with specialist assays for Poultry and Aquaculture. Equine diagnostic tests include Theileria equi, Pseudomonas aeruginosa, Streptococcus equi, EHV, Taylorella equigenitalis and influenza, and other new tests include Lyme disease, Dirofilaria immitis, Neospora caninum, Mec A gene for MRSA and IBR.

BEVA visitors will also be able to see HORIBA's LAQUAtwin Ca-11C waterproof, pocket ionized calcium (iCa) meter for on-site monitoring of ionized calcium, and HORIBA experts will be on hand to talk about the PC400 clinical chemistry analyzer.

HORIBA UK will also participate in Vets North (Haydock Park Racecourse, 15-16 September) so vets of all specialities can see HORIBA's accurate diagnostic instruments and discuss their use with the HORIBA Team.

* available from HORIBA in selected countries in Europe.

Disclaimer

Horiba Ltd. published this content on 17 August 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 17 August 2021 09:12:02 UTC.


© Publicnow 2021
All news about HORIBA, LTD.
10/20HORIBA : Technical Reports "Readout" No.55 is published
PU
10/19HORIBA : Acute myeloid leukemia type monoblastic (AML-M5b) - Clinical Cases of Yumizen...
PU
10/15HORIBA : Posted the presentation material for "SMBC Nikko Japan Series ESG Conference...
PU
10/15HORIBA : Posted the presentation material for "SMBC Nikko Japan Series ESG Conference Lond..
PU
10/14HORIBA : Veterinary haematology CPD webinar hosted by HORIBA to offer valuable best...
PU
10/06HORIBA : Development of the Partica CENTRIFUGE CN-300, Centrifugal Nanoparticle Analyzer ...
PU
10/04HORIBA : Scientific Validates the HORIBA Aqualog® Performance for Pharmaceutical...
PU
09/28VELODYNE LIDAR : Intelligent Traffic Monitoring Solution Chosen for Deployment at the Univ..
MT
09/28HORIBA : Sepsis and COVID - Clinical Cases of Yumizen H2500 Hematology Analyzers "Chase...
PU
09/16HORIBA : Scientific Partners with Covalent Metrology to Offer Glow Discharge...
PU
More news
Financials
Sales 2021 219 B 1 919 M 1 919 M
Net income 2021 20 269 M 178 M 178 M
Net cash 2021 37 969 M 333 M 333 M
P/E ratio 2021 15,7x
Yield 2021 1,79%
Capitalization 318 B 2 793 M 2 789 M
EV / Sales 2021 1,28x
EV / Sales 2022 1,21x
Nbr of Employees 8 269
Free-Float 91,6%
Chart HORIBA, LTD.
Duration : Period :
HORIBA, Ltd. Technical Analysis Chart | 6856 | JP3853000002 | MarketScreener
Technical analysis trends HORIBA, LTD.
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 9
Last Close Price 7 530,00 JPY
Average target price 8 337,50 JPY
Spread / Average Target 10,7%
EPS Revisions
Managers and Directors
Atsushi Horiba Chairman & Group Chief Executive Officer
Masayuki Adachi President & Representative Director
Sunao Kikkawa General Manager-Finance & Control Division
Juichi Saito Vice Chairman & Group Chief Operating Officer
Masao Okawa Managing Director & General Manager-Administration
Sector and Competitors
1st jan.Capi. (M$)
HORIBA, LTD.24.46%2 793
SMC CORPORATION4.83%38 549
COGNEX CORPORATION5.60%14 981
SHIMADZU CORPORATION15.34%12 124
MKS INSTRUMENTS, INC.-3.22%8 074
RENISHAW PLC-19.44%4 668